Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to investigate the safety and efficacy for long term treatment of the drug in children aged 6 months and < 5 years on bronchial asthma in daily clinical usage.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pulmicort Respules | Those with an exposure |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of Adverse Events | Range of 3 years | |
| Effects on growth rate | Variation of the height/weight from the baseline. | Range of 3 years |
| Effects on the adrenal cortical function. | Symptoms of adrenal cortical function suppression before and after the treatment with Pulmicort. | Range of 3 years |
| Effects on development of infections. | Existence and type of infections. | Range of 3 years |
| Measure | Description | Time Frame |
|---|---|---|
| Clinical course under Pulmicort long-term use | Validation of the frequency of asthmatic attack, level of the asthmatic attack, daily life, night sleep from baseline |
Not provided
Inclusion Criteria:
Not provided
Not provided
Patients treated with Pulmicort respules for the first time due to bronchial asthma and children of >=6months and <5 years old age at the start of study treatment
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Yoshida Shigeru, MD | AstraZeneca | Study Director |
Not provided
Not provided
| ID | Term |
|---|---|
| D001249 | Asthma |
| ID | Term |
|---|---|
| D001982 | Bronchial Diseases |
| D012140 | Respiratory Tract Diseases |
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| D012130 |
| Respiratory Hypersensitivity |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |